Duration of Dual Anti-Platelet Therapy Post-Percutaneous Intervention: Is There A Correct Amount of Time?

Progress in Cardiovascular Diseases
Kirk N Garratt

Abstract

Dual antiplatelet therapy (DAPT) is effective in preventing in-stent thrombosis (IST) after placement of drug-eluting coronary stents (DES) and in attenuating risk of athero-thrombotic events, primarily myocardial infarction, among patients with advanced coronary atherosclerosis. However, all studies of DAPT demonstrate an increased risk of moderate or severe bleeding for the duration of therapy. The extent of benefit and risk with various periods of DAPT after DES placement has been evaluated in multiple observational studies and randomized clinical trials. Most studies indicate little or no important reduction of ischemic events but significant increases in bleeding with prolonged treatment. The Dual Antiplatelet Therapy Study was the only randomized trial sufficiently powered to assess IST as an individual endpoint, and this study found that continuing DAPT from 12 to 30months after DES placement provided important reductions in IST and a composite of adverse ischemic events. When all data are considered, a cogent argument can be made for using just 3 to 6months DAPT in patients treated with contemporary second generation DES when the goal of treatment is to avoid IST. Longer therapy should be recommended for patients treate...Continue Reading

References

Sep 2, 1993·The New England Journal of Medicine·UNKNOWN GUSTO investigators
Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Aug 25, 2001·Lancet·S R MehtaUNKNOWN Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators
May 5, 2005·JAMA : the Journal of the American Medical Association·Ioannis IakovouAntonio Colombo
Dec 7, 2006·JAMA : the Journal of the American Medical Association·Eric L EisensteinRobert M Califf
Feb 14, 2007·The New England Journal of Medicine·Bo LagerqvistUNKNOWN SCAAR Study Group
May 2, 2007·Circulation·Donald E CutlipUNKNOWN Academic Research Consortium
Jul 1, 2008·American Heart Journal·Gregory J MishkelMarc E Shelton
Aug 30, 2008·The American Journal of Cardiology·Kenneth W BaranUNKNOWN ARRIVE Investigators
Sep 25, 2008·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·John M LasalaUNKNOWN ARRIVE 1 Participating Physicians
May 8, 2009·The New England Journal of Medicine·Stefan K JamesUNKNOWN SCAAR Study Group
Dec 25, 2009·Circulation. Cardiovascular Interventions·Sameer K MehtaUNKNOWN National Cardiovascular Data Registry
May 1, 2010·Journal of the American College of Cardiology·Douglass A Morrison
Oct 16, 2010·Journal of the American College of Cardiology·David R HolmesDavid J Moliterno
Feb 19, 2011·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Kenneth W BaranUNKNOWN ARRIVE Investigators
Nov 24, 2011·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Giuseppe MusumeciDominick J Angiolillo
Nov 24, 2012·JACC. Cardiovascular Interventions·George D DangasGregg W Stone
Jan 15, 2013·European Heart Journal·Marco ValgimigliUNKNOWN PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY Investigators
Mar 15, 2014·European Heart Journal·Edoardo CamenzindUNKNOWN PROTECT Steering Committee and Investigators
May 27, 2014·The American Journal of Cardiology·Georges El-HayekJacqueline E Tamis-Holland
Aug 30, 2014·Journal of the American College of Cardiology·Giulio G StefaniniStephan Windecker
Jan 30, 2015·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Martyn R ThomasKeith D Dawkins

❮ Previous
Next ❯

Citations

Apr 20, 2016·Progress in Cardiovascular Diseases·Konstantinos Dean BoudoulasHarisios Boudoulas
Jul 12, 2017·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·In-Ho BaeMyung Ho Jeong

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.